Skip to main content

Pacira BioSciences, Inc.

PCRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001396814

In the last 90 days, Pacira BioSciences, Inc. insiders filed 0 open-market purchases and 1 sale; 254 institutions reported holding it in 13F filings for Q2 2026, worth $1.11B in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Pacira BioSciences, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of PCRX: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders2393261+25
Shares48.0M118.3K47.0M−892.1K (−1.9%)
Value$1.24B$3.05M$1.22B−$17.8M (−1.4%)

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (49)

Institutions that held Pacira BioSciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to PCRX in Q4 2025
InstitutionSharesValue% of portfolio
Hillsdale Investment Management Inc.308,200$7.98M0.22%
Cambridge Investment Research Advisors, Inc.105,145$2.72M0.01%
Verition Fund Management LLC85,389$2.21M0.01%
XTX Topco Ltd82,906$2.15M0.06%
Campbell & CO Investment Adviser LLC78,345$2.03M0.10%
Keating Financial Advisory Services, Inc.71,343$1.85M0.25%
Integrated Quantitative Investments LLC64,826$1.68M0.36%
Milestone Asset Management, LLC51,105$1.32M0.25%
Freestone Grove Partners LP36,832$953.2K0.01%
Lighthouse Investment Partners, LLC28,415$735.4K0.02%
Susquehanna International Group, LLP27,294$706.4K0.00%
EntryPoint Capital, LLC26,182$677.6K0.26%
Guggenheim Capital LLC25,224$652.8K0.00%
Three Seasons Wealth, LLC23,331$603.8K0.06%
Schonfeld Strategic Advisors LLC23,304$603.1K0.00%
Skopos Labs, Inc.20,064$522.9K0.02%
Steward Partners Investment Advisory, LLC20,189$522.5K0.00%
Versor Investments LP18,900$489.1K0.08%
Raymond James Financial Inc17,556$454.3K0.00%
Axq Capital, LP15,316$396.4K0.09%
Fox Run Management, L.L.C.14,092$364.7K0.06%
Lion Point Capital, LP13,500$349.4K1.81%
Cetera Investment Advisers13,359$345.7K0.00%
Mitsubishi UFJ Trust & Banking Corp10,374$268.5K0.00%
Rafferty Asset Management, LLC9,285$240.3K0.00%
Abacus Wealth Partners, LLC8,495$219.9K0.02%
Toroso Investments, LLC8,411$217.7K0.00%
Swiss Life Asset Management Ltd7,968$206.2K0.00%
Roxbury Financial LLC6,222$161.0K0.14%
Pinnacle Wealth Planning Services, Inc.4,026$104.2K0.01%
Los Angeles Capital Management LLC4,725$100.5K0.00%
Estate Planners Group, LLC3,310$85.7K0.04%
Eurizon Capital SGR S.p.A.1,961$51.1K0.00%
Kestra Advisory Services, LLC1,869$48.4K0.00%
Litman Gregory Asset Management LLC750$19.4K0.00%
Signature Equity Partners, LLC724$18.7K0.01%
Torren Management, LLC374$9.68K0.00%
SRS Capital Advisors, Inc.178$4.61K0.00%
Quarry LP150$3.88K0.00%
Rachor Investment Advisory Services, LLC80$2.07K0.00%
Sound Income Strategies, LLC83$1.59K0.00%
Elequin Capital LP54$1.40K0.00%
Cornerstone Financial Management LLC51$1.32K0.00%
Spire Wealth Management21$5430.00%
CIBC Private Wealth Group, LLC10$2590.00%
Flagship Harbor Advisors, LLC7$1810.00%
Ankerstar Wealth, LLC5$1290.00%
Gilpin Wealth Management, LLC2$520.00%
Dunhill Financial, LLC1$240.00%

Sold out (24)

Institutions that held Pacira BioSciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (3)

Institutions that held Pacira BioSciences, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding PCRX in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
AXA Investment Managers S.A.117,285$3.02M
Shell Asset Management Co1,014$26.0K
Binnacle Investments Inc8$206